Intratumoural administration of cisplatin in slow-release devices: II. pharmacokinetics and intratumoural distribution

Marc J. M. Deurloo(Oncode Institute), Adrian C. Begg(The Netherlands Cancer Institute), Olaf van Tellingen(Dutch Cancer Society), Wim Kop(The Netherlands Cancer Institute), Harry Bartelink(Radboud University Nijmegen)
Cancer Chemotherapy and Pharmacology
September 1, 1991
10.1007/bf00688856
Cited by 49

Related Papers

A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
|Cell|1994|2.3k
Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial
|Journal of Clinical Oncology|2007|1k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
|New England Journal of Medicine|2015|1k